2025 AI Stock Picks: 2 Hidden Gems Under $10/Share

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

Nicholas Sheridan Lewin net worth and biography

Nicholas Lewin Biography and Net Worth

Director of Establishment Labs

Mr. Lewin has served on our board of directors since September 2015. He has been a Managing Partner at Crown Predator Holdings since 2000 and has been a private investor since 2000. He has invested across multiple industries, and throughout the capital structure, with a particular focus on companies with innovative technologies and strong intellectual property, including activist situations that require working with management. He has been a director of Halo Maritime Defense Systems, a privately held provider of maritime security product and solutions, since 2007. Mr. Lewin holds a bachelor’s degree in Political Science from Johns Hopkins University.

What is Nicholas Sheridan Lewin's net worth?: The estimated net worth of Nicholas Sheridan Lewin is at least $44.52 million as of December 14th, 2023. Mr. Lewin owns 1,064,888 shares of Establishment Labs stock worth more than $44,522,967 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Lewin may own. Learn More about Nicholas Sheridan Lewin's net worth.
How do I contact Nicholas Sheridan Lewin?: The corporate mailing address for Mr. Lewin and other Establishment Labs executives is Building B15 and 25 Coyol Free Zone, Alajuela G2, . Establishment Labs can also be reached via phone at (062) 434-2400 and via email at [email protected]. Learn More on Nicholas Sheridan Lewin's contact information.
Has Nicholas Sheridan Lewin been buying or selling shares of Establishment Labs?: Nicholas Sheridan Lewin has not been actively trading shares of Establishment Labs during the last quarter. Most recently, on Thursday, December 14th, Nicholas Sheridan Lewin bought 2,000 shares of Establishment Labs stock. The stock was acquired at an average cost of $27.04 per share, with a total value of $54,080.00. Following the completion of the transaction, the director now directly owns 1,064,888 shares of the company's stock, valued at $28,794,571.52. Learn More on Nicholas Sheridan Lewin's trading history.
Who are Establishment Labs' active insiders?: Establishment Labs' insider roster includes Juan Chacon-Quiros (Founder), Dennis Condon (Director), Roberto de Mezerville (CTO), Renee Gaeta (CFO), Lisa Gersh (Director), Nicholas Lewin (Director), and Edward Schutter (Director). Learn More on Establishment Labs' active insiders.
Are insiders buying or selling shares of Establishment Labs?: During the last twelve months, Establishment Labs insiders bought shares 1 times. They purchased a total of 2,000 shares worth more than $54,080.00. During the last twelve months, insiders at the sold shares 3 times. They sold a total of 14,346 shares worth more than $647,806.00. The most recent insider tranaction occured on July, 11th when CEO Quiros Juan Jose Chacon sold 3,641 shares worth more than $163,990.64. Insiders at Establishment Labs own 11.4% of the company. Learn More about insider trades at Establishment Labs.
Information on this page was last updated on 7/11/2024.

Nicholas Sheridan Lewin Insider Trading History at Establishment Labs

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/14/2023	Buy	2,000	$27.04	$54,080.00	1,064,888
11/20/2023	Buy	5,000	$22.00	$110,000.00	14,190
3/17/2021	Buy	350	$59.97	$20,989.50	780,463
8/19/2019	Buy	2,700	$20.11	$54,297.00

Nicholas Sheridan Lewin Buying and Selling Activity at Establishment Labs

Establishment Labs Company Overview

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Today's Range

Now: $41.81

$37.10

$41.99

50 Day Range

MA: $42.95

$37.51

$48.81

2 Week Range

Now: $41.81

$21.25

$60.12

Volume

996,952 shs

Average Volume

491,578 shs

Market Capitalization

$1.17 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2